Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP

NCT07656909 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Kaposiform Hemangioendothelioma (KHE)
Kasabach Merritt Phenomenon

Interventions

DRUG: Sirolimus (RAPAMUNE)

Sponsor

Yi Ji